Skip to content
Contact us
MAT Splash
Pharma Marketing Asset Testing
 

Launch the Version That Already Won

Marketing Asset Testing (MAT) lets pharma brand teams A/B test messages, concepts, and creative assets with real HCPs — before production, before the shoot, before the launch. From brief to actionable insights in days, not weeks.
schedule a demo
100
+

Leading Biopharma Companies Trust ZoomRx

60
K+
Proprietary HCP panel members
700
M+
Real-world benchmark datapoints
15
+
Years of Life sciences research expertise

Where Traditional Pharma Marketing Testing Falls Short 

Most pharma creative is validated only after it's nearly built — when direction is locked and feedback can do little but tweak the words.
Brand Teams Commit Production Before Knowing What Works

In pharma marketing, the biggest commitment isn't the research — it's the production. Testing after the shoot locks you into a direction the audience may not pick.

Testing Takes Weeks — After the Decision Is Already Made

Traditional research timelines run weeks or months. By the time results arrive, the campaign is in production. MAT fields to real HCPs in days and synthetic respondents in minutes.

Research Covers Known Answers — Not Open Questions

Without upfront intelligence, teams test in the dark — validating themes competitors already own. Every MAT study starts with a read of real HCP-patient conversations and competitive signals.

MAT

Marketing Asset Testing

One Platform. Creates the Asset. Tests It. Learns After Launch.
MAT builds the thing to test — pointed by the market intelligence it gathered first. Describe your objective in plain language and iterate.
Behind the conversation, four moves run as one continuous loop:
Know → Create → Validate → Launch
 
No competitor creative tool does this end to end: generic AI generates but never tests; survey tools test only what you bring. MAT does both — for messages, still images, and video alike.
Powered by Sagan Logo
ZoomRx's Proprietary AI Engine
Learn more about Sagan Agents

Core Value Pillars

faster
From Brief to Actionable Insights 

Design, build, and field in one AI-augmented flow. Real HCP results in days; synthetic results in minutes.

cost
A Fraction of Traditional Research Cost
Many small decisions, not one big study. Test the hypothesis at the moment it's cheapest to change — before production is funded.
confidence
Confidence, Not Crossed Fingers

Launch the version that already won. Behavioral methods — MaxDiff, conjoint, pairwise, flash-recall, scroll tests — measure what HCPs do, not just what they say.

not a black box
Not a Synthetic Black Box

Backed by a 60,000+ proprietary HCP panel with humans in the loop. Every test is traceable to a real-world signal.

How MAT Works — One Closed Loop

Know. Create. Validate. Launch. Four moves running as one continuous loop — with listening after launch feeding the next pass.
Know
Know

Intelligence — what's already known from HCP-patient conversations, competitive channels, and social signals.

Create
Create

Generate the asset — messages, images, video — sharpened by intelligence before a single test is run.

validate
Validate

A/B test with real HCPs, synthetic respondents, or both — in days, not weeks.

launch
Launch

Go to market with the version the audience already picked — then keep listening.

After launch, MAT keeps listening — the gap between predicted and actual performance in live HCP-patient conversations becomes the brief for the next test.

The Four Working Models

Intelligence

Know Before You Ask
Decode signal Unmet needs White space Brief

 

Before a single question is asked, MAT reads real HCP-patient conversations, competitor promotion, and social intelligence. It maps what's known, surfaces white space, and hands the test a pre-loaded brief — so research covers only open questions.

Create

Built It Before You Test It
Message Labs Image Labs Video Labs

 

Message Labs drafts, scores, and sharpens claims. Image Labs generates and versions concepts. Video Labs recasts and restages reference spots. The winning version flows straight into Validate — one click, no re-upload.

Validate

Test in Minutes or Days
Real HCPs Synthetic MaxDiff Conjoint Flash-recall

 

Design, build, and field in one flow — to real HCPs, synthetic respondents, or a blend of both. Behavioral methods (MaxDiff, conjoint, pairwise, flash-recall, scroll tests) measure memory, attention, and trade-offs. 

 

Report & Listen

Answers, Not Data Dumps
Instant report Conversational Q&A Post-launch listening

 

Actionable findings the moment field closes. A conversational layer answers follow-up questions and traces every insight to its source. After launch, social listening tracks whether the deployed asset echoes and converts in live HCP-patient conversations.

 

Complete Commercial Intelligence

Combine MAT with ZoomRx's broader tracking suite for full market visibility.

Promotional Effectiveness Tracking (PET)

Measure the real-world impact of the assets MAT helped you optimize — connecting tested creative to actual prescribing behavior.

Learn more
HCP-Patient
Conversations
The same conversation data that feeds MAT's Intelligence module, available as a standalone offering for messaging pull-through analysis.

 

Learn more
Brand Tracking (ATU)

Track brand perception alongside asset performance — understand whether optimized creative is moving awareness, trial, and usage metrics.

Learn more

Explore Insights

SLE-Treatment-unmet-needs
Five Key Unmet Needs in Lupus Treatment
read more
blog
How Shared Clinical Decision-Making Is Changing Pediatric Vaccine Conversations—And What Manufacturers Must Do
read more
Oncology (1)
Oncology Manufacturer Perception Rankings 2025: Which Companies Control the "Awareness Wall"?
read more

CTA

Launch With Confidence. Not a Hunch

See MAT test and iterate your own pharma marketing asset, with your real HCP audience, in a single session.

Get in touch

Frequently Asked Questions

What is marketing asset testing (MAT) in pharma?

Marketing asset testing (MAT) in pharma is the practice of A/B testing messages, claims, concepts, and creative assets — such as emails, banners, rep aids, and TV ads — with real HCP or patient audiences before production commitments are made. MAT builds the asset, gathers pre-test competitive and social intelligence, runs the test, and delivers actionable insights in days rather than weeks.

How does MAT differ from traditional pharma message testing?

Traditional pharma message testing validates creative only after production is nearly complete — when direction is already locked. MAT moves testing upstream: it tests messages and concepts while they are still hypotheses, using behavioral methods (MaxDiff, conjoint, pairwise, flash-recall, scroll tests) and a 60,000+ proprietary HCP panel, so production investment is committed only to the winning direction.

What types of pharma marketing assets can MAT test?

MAT can create and test messages, claims, positioning, emails, banners, rep aids, concepts, campaigns, TV and video ads, and logos. Its three creative labs — Message Labs, Image Labs, and Video Labs — cover the full spectrum of pharma promotional assets from copy through finished video.

Does MAT use real HCPs or synthetic respondents?

MAT is backed by a 60,000+ proprietary HCP panel. Teams can field to real HCP audiences, synthetic respondents, or a blend of both. Synthetic respondents deliver results in minutes; real HCPs deliver results in days. MAT is not a synthetic-only tool — users can field to real HCPs, or a mix of real and synthetic HCPs. Humans are always in the loop during decision making, and every insight is traceable to its source.

How does MAT gather competitive intelligence before testing?

MAT's Intelligence module reads real HCP-patient conversations, competitor promotional channels, and social signals before any question is asked. It surfaces unmet needs, white space — classifying each theme as Hidden Gem, Unoccupied, Reframe, or Owned — and hands the user an intelligence report and a research brief so new research covers only open questions, not already-known answers.

How long does a MAT study take?

MAT delivers insights in minutes (synthetic respondents) to days (real HCP audiences), compared to weeks or months for traditional pharma primary research. The end-to-end flow — gather intelligence, generate the asset, design and field the test, receive actionable findings — runs as one continuous loop with no re-uploads or handoffs between tools.

What research methods does MAT use to measure asset performance?

MAT uses behavioral, derived or choice-based measurement methods — including sentiment analysis, MaxDiff, conjoint analysis, pairwise comparison, flash-recall, and scroll tests — that measure memory, attention, emotional association and trade-offs rather than simple rating grids. This produces a stronger signal of what HCPs will actually do, not just what they report they prefer.

What happens after a pharma marketing asset is launched with MAT?

After launch, MAT's social listening engine continues tracking whether the deployed asset echoes and converts in live HCP-patient conversations. Predicted versus observed performance is compared, and the gap automatically becomes the brief for the next test — so intelligence compounds with each campaign rather than resetting.